Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for Osimertinib
Tagrisso (osimertinib) received FDA approval on November 13, 2015.[1]
The November 13, 2015 date refers to the drug’s original FDA approval. Subsequent FDA approvals for additional indications and label updates can have different dates than the original approval.[1]
You can confirm the approval timing on DrugPatentWatch.com’s listing for osimertinib/Tagrisso.[1]
Other Questions About Osimertinib :